Fonte: Breast Cancer Research. Unidade: FM
Assuntos: BIOMARCADORES, ANTINEOPLÁSICOS (APLICAÇÕES TERAPÊUTICAS), CO-TERAPIA, TÉCNICAS BIOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHNEEWEISS, Andrea et al. Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study. Breast Cancer Research, v. 16, n. 4, p. R73, 2014Tradução . . Disponível em: http://breast-cancer-research.com/content/pdf/bcr3690.pdf. Acesso em: 24 abr. 2024.APA
Schneeweiss, A., Chia, S., Hegg, R., Tausch, C., Deb, R., Ratnayake, J., et al. (2014). Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study. Breast Cancer Research, 16( 4), R73. Recuperado de http://breast-cancer-research.com/content/pdf/bcr3690.pdfNLM
Schneeweiss A, Chia S, Hegg R, Tausch C, Deb R, Ratnayake J, Mcnally V, Ross G, Kiermaier A, Cortés J. Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study [Internet]. Breast Cancer Research. 2014 ; 16( 4): R73.[citado 2024 abr. 24 ] Available from: http://breast-cancer-research.com/content/pdf/bcr3690.pdfVancouver
Schneeweiss A, Chia S, Hegg R, Tausch C, Deb R, Ratnayake J, Mcnally V, Ross G, Kiermaier A, Cortés J. Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study [Internet]. Breast Cancer Research. 2014 ; 16( 4): R73.[citado 2024 abr. 24 ] Available from: http://breast-cancer-research.com/content/pdf/bcr3690.pdf
